Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Dieplinger

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Personalized Medicine|May 28, 2022
Gender-Specific Differences in the Intensive Care Treatment of COVID-19 PatientsPeter Jirak, Moritz Mirna, Vincent Van Almsick, et al.
Frontiers in Pharmacology|June 16, 2023
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivorsLukas Fiedler, Lukas J Motloch, Anna-Maria Dieplinger, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Personalized Medicine|May 28, 2022
Gender-Specific Differences in the Intensive Care Treatment of COVID-19 PatientsPeter Jirak, Moritz Mirna, Vincent Van Almsick, et al.
Frontiers in Pharmacology|June 16, 2023
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivorsLukas Fiedler, Lukas J Motloch, Anna-Maria Dieplinger, et al.
Pageof 2